Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Wednesday 03 June, 2020

BlackRock Group

Form 8.3 - Willis Towers Watson Plc

RNS Number : 8297O
BlackRock Group
03 June 2020
 

Ap19

 

 

FORM   8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.  KEY   INFORMATION

 

Nameofpersondealing (Note 1)

BlackRock, Inc.

Companydealtin

Willis Towers Watson plc

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 2)

US$0.000304635 ordinary shares

Date of dealing

02 June 2020

 

2.  INTERESTS AND SHORT POSITIONS

 

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note   3)

 

Long

Short

 

Number

 

(%)

Number

(%)

(1)Relevantsecurities

11,122,566 (8.63%)

0 (0.00%)

(2) Derivatives (other than options)

147,852 (0.11%)

9,665 (0.00%)

(3)Optionsandagreementstopurchase/sell

0 (0.00%)

76,800 (0.05%)

Total

11,270,418 (8.75%)

86,465 (0.06%)

             

 

(b)  Interests and short positions in relevant securities of the company, other than the class dealt in  (Note   3)

Classofrelevantsecurity:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1)Relevantsecurities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3)Optionsandagreementstopurchase/sell

 

 

Total

 

 

             

 

Ap20

 

 

1.  DEALINGS  (Note   4)

 

(a)  Purchases and sales

 

 

 

Purchase/sale

 

Numberofrelevantsecurities

 

Priceperunit (Note 5)

Purchase

10,707

USD 201.1300

Purchase

196

USD 201.9051

Sale

1,257

USD 201.1300

Sale

193,370

USD 201.9270

Sale

38

USD 201.9900

Sale

290

USD 202.4863

Sale

53,238

USD 202.5414

Sale

37

USD 203.4700

 

Please note: there was also a Transfer Out of 3,360 Shares

 

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

e.g. CFD

Natureoftransaction

(Note 6)

Numberofrelevantsecurities

(Note 7)

Priceperunit

(Note 5)

 

 

 

 

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing, selling, purchasing or varying

 

Productname,

e.g. call option

Writing, selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates (Note 7)

Exercise price

Type, e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit (Note 5)

 

 

 

 

 

 

 

 

(ii)  Exercising

 

Productname,

e.g. call option

Numberofsecurities

Exercisepriceper unit (Note 5)

 

 

 

 

(d)  Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

Stock on Loan

100

N/A

 

 

Ap21

 

2.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the 

voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition 

or   disposal   of   any  relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

None

 

 

 

Is a Supplemental Form 8 attached?  (Note   9)   YES

 

Dateofdisclosure

03 June 2020

Contact name

Jana Blumenstein

Telephone number

+44 20 7743 3650

If aconnectedEFM,nameofofferee/offerorwithwhichconnected

 

If aconnectedEFM,statenatureofconnection (Note 10)

 

 

 

 

Ap23

 

 

SUPPLEMENTAL FORM 8

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DETAILS OF OPEN POSITIONS

 

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

 

OPEN POSITIONS (Note 1)

 

Productname,

e.g.calloption

Written,orpurchased

Numberofrelevant securitiestowhichtheoptionorderivativerelates

Exercise price(Note2)

Type,e.g.American,Europeanetc.

Expiry date

Call Option

Written

46,000

USD 201.7260

European

15/06/2020

Call Option

Written

30,500

USD 210.0000

American

17/07/2020

Call Option

Written

300

USD 210.0000

American

19/06/2020

 

Notes

 

1.  Where there are open option positions or open derivative positions (except for CFDs), full details should be given. 

Full details of any existing agreements to purchase or to sell must also be given on this form.

 

2.  For all prices and other monetary amounts, the currency must be stated.

 

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEFJMMTMTBMBJM

a d v e r t i s e m e n t